Digital Treatment for Osteoarthritis Superior to Traditional Routine Care

Joint AcademyFirst-line treatment of knee osteoarthritis is effectively delivered digitally without a need for traditional face-to-face physiotherapy visits, a new study finds. The research, independently undertaken by the University of Nottingham, led by Prof Ana Valdes from the Nottingham NIHR Biomedical Research Centre using Joint Academy's clinical and evidence-based digital treatment for chronic joint pain, addresses a rapidly growing health concern as hospital waiting lists are mounting while the NHS is expected to spend £118.6 billion on treating arthritis between 2017 and 2027 alone. The study, published today, shows that UK patients receiving digital treatment reduced their pain by 41 per cent, while the same number for patients receiving usual care landed at merely 6 per cent.

"We already knew that digital first-line treatment substantially improves symptoms of osteoarthritis at a significantly reduced cost compared to face-to-face care. This study is the first randomised controlled trial that demonstrates clinically important improvements of digital treatment compared to the traditional one and firmly establishes how effective digital treatment actually is in relation to traditional self-management care," says Leif Dahlberg, Chief Medical Officer at Joint Academy and Senior Professor in Orthopedics.

A total of 105 people, who were 45 years or older with a diagnosis of knee osteoarthritis, participated in the study. They were allocated at random to two groups where one was treated digitally and the other group self-managed their symptoms according to NICE guidelines. Patients in the digital treatment were connected with licensed physiotherapists via a smartphone application where they received education and daily exercises. Patients in the other group continued their traditional self-management programme according to guidelines and visited their general practitioner when needed. In addition to experiencing substantially less pain than the control group, the patients receiving digital treatment also reported that their physical function increased by 48 per cent - a stark improvement to traditional treatment where physical function increased by only 13 per cent.

"The results of the study really show how much can be gained by treating chronic knee pain digitally, and this will reduce the burden on the NHS, especially when we are going through the COVID-19 pandemic where services are already stretched. We hope this study allows health policy-makers to consider the potential in digital alternatives when it comes to treating knee arthritis," says Sameer Akram Gohir, physiotherapist and researcher at the University of Nottingham.

Osteoarthritis is one of the world’s fastest-growing and most costly chronic diseases. Figures from the NHS show that nearly 9 million people are impacted in the UK alone and Arthritis Research UK estimates that roughly 20 per cent of the English population aged 45 and over suffer from osteoarthritis of the knee, but the recommended first-line treatment, consisting of information, exercise and weight control when needed, is underutilised.

"The study shows the positive impact digital treatment has on the osteoarthritis burden for both patients and healthcare systems. Besides the beneficial outcomes in pain and physical function, the advantages of digital treatment are also lower costs and more easily accessible care for those living in remote areas far from the nearest physiotherapist," Dahlberg concludes.

Joint Academy connects patients with licensed physiotherapists to deliver its evidence-based osteoarthritis treatment through telehealth, making it a safe treatment option during the COVID-19 pandemic. Already one of the main providers of chronic joint pain treatment in Sweden, Joint Academy is planning to expand across the UK throughout 2021.

About the study

The study was conducted by an independent group of five researchers at the University of Nottingham in the UK during a period of six weeks. 105 people aged 45 and over and diagnosed with knee osteoarthritis participated in the study. All participants had a face-to-face meeting during enrolment. The treatment was then delivered digitally to the intervention group using Joint Academy’s clinical and evidence-based digital treatment for osteoarthritis, whereas the patients in the control group continued a traditional self-management programme according to general guidelines and visited a general practitioner when needed. The study is named "Randomised controlled trial of Digitally delivered first-line knee osteoarthritis treatment: the Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA) study" and was published in JAMA Network Open on February 23, 2021. The study can be found in full here.

About Joint Academy

Joint Academy is a treatment program based on clinical evidence and connects patients with licensed physiotherapists for a chronic joint pain treatment online. Through the program, patients receive important information and support to do necessary lifestyle changes that are sustainable, as well as individualized exercises to strengthen the affected joints and increase their function. The patients have a personal physiotherapist that guides them through the entire treatment.

Most Popular Now

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

Multimodal AI Poised to Revolutionize Ca…

Although artificial intelligence (AI) has already shown promise in cardiovascular medicine, most existing tools analyze only one type of data - such as electrocardiograms or cardiac images - limiting their...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...